Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
NewAmsterdam Pharma Company N.V. (NAMS) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
$0.35M |
|
$-72.00M |
|
-- |
|
$0.35M |
|
$55.49M |
|
$-55.14M |
|
$-16.86M |
|
$-72.00M |
|
$-72.00M |
|
$-72.00M |
|
$-72.00M |
|
$-72.00M |
|
$-72.00M |
|
$-55.14M |
|
$-55.08M |
|
119.00M |
|
119.00M |
|
$-0.61 |
|
$-0.61 |
|
| Balance Sheet Financials | |
$732.33M |
|
$0.32M |
|
$54.10M |
|
$786.43M |
|
$58.27M |
|
-- |
|
$0.09M |
|
$58.36M |
|
$728.07M |
|
$727.63M |
|
$728.07M |
|
113.17M |
|
| Cash Flow Statement Financials | |
$-106.91M |
|
$-153.78M |
|
$15.84M |
|
$771.74M |
|
$539.72M |
|
$-232.03M |
|
$45.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.57 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
100.00% |
|
-15845.69% |
|
-15845.69% |
|
-- |
|
-20691.09% |
|
-20691.09% |
|
$-107.05M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-9.89% |
|
-9.90% |
|
-9.16% |
|
-9.89% |
|
$6.43 |
|
$-0.90 |
|
$-0.90 |
|